Previous Article | Next Article 
Infect Immun, May 1998, p. 2040-2051, Vol. 66, No. 5
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Characterization of the Roles of Hemolysin and Other Toxins
in Enteropathy Caused by Alpha-Hemolytic Escherichia
coli Linked to Human Diarrhea
Simon J.
Elliott,1,2,*
S.
Srinivas,3
M. John
Albert,4
Khorshed
Alam,4
Roy M.
Robins-Browne,5
Stuart T.
Gunzburg,2
Brian J.
Mee,2 and
Barbara J.
Chang2
Center for Vaccine
Development1 and
Department of
Comparative Medicine and Pathology,3 University
of Maryland School of Medicine, Baltimore, Maryland 21201;
International Center for Diarrheal Disease Research, Dhaka,
Bangladesh4; and
Department of
Microbiology, The University of Melbourne, Parkville, Victoria
3052,5 and
Department of
Microbiology, The University of Western Australia, Nedlands,
Western Australia 6009,2 Australia
Received 5 September 1997/Returned for modification 23 October
1997/Accepted 29 January 1998
 |
ABSTRACT |
Escherichia coli strains producing alpha-hemolysin have
been associated with diarrhea in several studies, but it has not been clearly demonstrated that these strains are enteropathogens or that
alpha-hemolysin is an enteric virulence factor. Such strains are
generally regarded as avirulent commensals. We examined a collection of
diarrhea-associated hemolytic E. coli (DHEC) strains for
virulence factors. No strain produced classic enterotoxins, but they
all produced an alpha-hemolysin that was indistinguishable from that of
uropathogenic E. coli strains. DHEC strains also produced
other toxins including cytotoxic necrotizing factor 1 (CNF1) and novel
toxins, including a cell-detaching cytotoxin and a toxin that causes
HeLa cell elongation. DHEC strains were enteropathogenic in the RITARD
(reversible intestinal tie adult rabbit diarrhea) model of diarrhea,
causing characteristic enteropathies, including inflammation, necrosis,
and colonic cell hyperplasia in both small and large intestines.
Alpha-hemolysin appeared to be a major virulence factor in this model
since it conferred virulence to nonpathogenic E. coli
strains. Other virulence factors also appear to be contributing to
virulence. These findings support the epidemiologic link to diarrhea
and suggest that further research into the role of DHEC and
alpha-hemolysin in enteric disease is warranted.
 |
INTRODUCTION |
Escherichia coli is one
of the major causes of human infectious diseases, partly because of the
wide variety of virulence mechanisms and pathotypes (15),
and new pathotypes continue to be described. A new pathotype was
proposed by Gunzburg et al. after examining diarrheal pathogens in
a prospective community-based study among Australian Aboriginal
children (22). One group of isolates was significantly
(P < 0.05) associated with diarrhea, and these
isolates were particularly common among children younger than 18 months. The isolates did not produce any recognized enterotoxin or
classic enteric virulence factor, although they exhibited diffuse or
aggregative adhesion in a modified adhesion assay (15). All isolates were able to detach HEp-2 cell monolayers and were termed "cell-detaching E. coli." This property was shown to be
mediated by alpha-hemolysin, and we demonstrate below that all
cell-detaching E. coli strains produce alpha-hemolysin and
that some may also produce cytotoxic necrotizing factor 1 (CNF1) and
other toxins. However, neither alpha-hemolysin nor CNF1 has been
clearly demonstrated to be an enteric virulence factor, and the role of
hemolysin in particular is controversial. We will refer to these
isolates as diarrhea-associated hemolytic E. coli (DHEC)
isolates.
Alpha-hemolytic E. coli strains have been associated with
human enteric disease, especially among young children (8, 10-12, 20-22), and the related enterohemolysin of E. coli
O157 (35) appears to be involved in enteric disease. There
has, however, been no large prospective case-controlled epidemiologic
study of the association of alpha-hemolysin with human diarrhea.
Alpha-hemolytic bacteria are also associated with enteric disease and
diarrhea in pigs, cattle, and dogs (9, 13, 33, 36, 44, 45). Porcine diarrheal strains are almost universally hemolytic
(23a), and alpha-hemolysin in these isolates enhanced
virulence and colonization (37) but was not itself
diarrheagenic. More recent studies have found that Hly+
CNF1+ strains caused fluid accumulation in piglets
(33) and that neonatal pigs were susceptible to challenge
with Hly+ CNF+ strains, which caused bloody
diarrhea, enterocolitis, and systemic disease (45).
In contrast, some earlier studies were unable to demonstrate a role for
hemolysin in enteric disease, since neither hemolytic bacteria nor
their supernatants caused fluid accumulation in ileal loops (10,
14, 37). Hemolytic strains may be isolated from the feces of
asymptomatic people (26), and, among humans, hemolysin is
more commonly associated with strains causing extraintestinal infections (5, 26).
The genetics and in vitro mechanisms of alpha-hemolysin are well known.
The hlyCABD operon encodes the structural 110-kDa hemolysin
protein (HlyA) and proteins involved in processing and export
(42). Once secreted, hemolytic activity is short-lived, and
this has complicated studies of hemolysin toxigenicity (42). Hemolysin does not require a receptor to bind to target cells, inserting instead into the target cell membrane to form a pore that
allows the free flow of cations, sugars, and water. This leads to
leakage of intracellular contents and affects the cytoskeleton and
metabolism (4, 9, 42, 43). In extraintestinal infections, hemolysin has multiple effects and roles, including resistance to host
defense, tissue damage, and lethality, either by direct action or by
stimulation of inflammatory mediators and signal transduction pathways
(7, 9, 16, 42).
CNF is a 114-kDa protein with homology to a family of dermonecrotic
toxins (18) and is encoded by the monocistronic
cnf gene, which lies just downstream of hly. The
CNF1 toxin causes HeLa cells to become large and multinucleated as a
result of actin disassembly, which results from activation of Rho
(10, 19, 31). Similar to alpha-hemolysin, the role of CNF1
in diarrhea remains unclear. CNF1-producing strains have been isolated
from diarrheal stools and have been associated with several outbreaks in humans (8, 10) and animals (13, 33, 44).
Unfortunately, no large, prospective, case-controlled studies have been
performed, and the best evidence for the pathogenicity of
CNF1-toxigenic isolates is the marked virulence in piglet challenge
experiments (45), outlined above. Purified CNF1 did not show
enterotoxic potential in the suckling mouse or induce fluid
accumulation in the rabbit ileal loop (10, 14), in contrast
to the related CNF2, which is linked to enteric disease in animals
(13, 14, 30). Both CNF toxins are extremely lethal, and have
a variety of in vivo effects including tissue necrosis and edema
(12-14).
In this paper, we characterize DHEC isolates that were obtained from a
study where alpha-hemolysin was significantly associated with disease
(22) and show that they are able to cause disease in
rabbits. Using molecular genetics, we attempt to analyze the role of
each gene in pathogenesis.
 |
MATERIALS AND METHODS |
Bacterial strains and plasmids.
A collection of 177 DHEC
strains were obtained as part of a study of diarrheal virulence factors
(22), and 3 of these isolates were selected for further
study (Table 1). Also listed are mutant variants of wild-type DHEC and plasmids including cloned constructs of
hly and cnf genes from strain A70.1 and strains
used in mutagenesis.
Assays for cell detachment, alpha-hemolysin, and CNF.
Cell
detachment was assayed as described by Gunzburg et al. (22).
A semiconfluent monolayer of HEp-2 cells in a 24-well tissue culture
tray was washed three times with phosphate-buffered saline (PBS)
supplemented with CaCl2 and MgCl2 (each at
0.01%) (PBS-CM), and 1 ml of PBS-CM was added to each well. A 10-µl
volume of log-phase bacterial culture was added, and the plate was
incubated at 37°C for 90 min under 5% CO2. Monolayers
were washed three times with PBS-CM, fixed with 70% methanol for 10 min, stained with 0.13% crystal violet for 10 min, and then briefly
destained in water. Significant destruction of the monolayer was
recorded as cell detachment and was quantified by eluting crystal
violet with a solution of 50% ethanol, 49% water, and 1% sodium
dodecyl sulfate (SDS) and measuring the absorbance of the eluate at 590 nm. Alpha-hemolysin was detected by the presence of characteristic zones of lysis on Columbia agar (Oxoid) containing 5% washed sheep erythrocytes, with observation at 4 h and again after overnight incubation, as described by Beutin (5).
CNF was detected by the method of Oswald et al. (30) by
assaying the ability of freeze-thawed bacterial lysates to cause characteristic multinucleation, cytotoxicity, and morphological changes
to HeLa cells. CNF activity was quantified as the 50% multinucleation
titer (MN50), the maximal dilution able to cause multinucleation in 50% of HeLa cells. Antibody neutralization of CNF
activity was demonstrated by preincubation of the lysate overnight at
37°C with neutralizing antiserum before addition to HeLa cells.
Antisera to CNF1 and CNF2 were kindly provided by A. Caprioli,
Instituto Superiore di Sanità, Rome, Italy.
Molecular genetic techniques.
DNA preparation, cloning,
manipulation, and Southern hybridizations were performed as described
by Sambrook et al. (34) unless otherwise stated. Transposon
mutagenesis with Tn1725 was performed by the method of Ubben
and Schmitt (41). Chromosomal DNA was prepared by the method
of Ausubel et al. (2).
To clone virulence factors from A70.1, chromosomal DNA of A70.1 was
partially digested with Sau3AI and ligated into the
BamHI site of pHC79. Concatamers were packaged into phage
heads and transfected into E. coli HB101 as specified by the
manufacturer (Amersham
DNA in vitro packaging kit). A total of 412 colonies were screened for cell detachment and alpha-hemolysin.
A 4.3-kb fragment containing cnf was sequenced by the method
of Bankier et al. (3), and a library of contiguous, randomly sheared fragments was constructed. Double-stranded DNA sequencing was
performed with the Advanced Biosystems Inc. (ABI) Prism dye terminator
sequencing kit, as specified by the manufacturer, and an ABI automatic
sequencer. The sequence was complied and analyzed with software
packages MacVector for the Macintosh and tfasta, fasta, and align
written for Unix.
Chromosomal mutagenesis by marker exchange.
Mutagenesis of
chromosomal genes was performed by the method of Penfold and Pemberton
(32). A DNA fragment internal to the gene of interest was
cloned into pJP5603 or pJP5608, which contain a lacZ with a
multiple-cloning site from pUC18 and a pir-dependent R6K
origin of replication. Transformants containing the insert of interest
were first screened in JM109
pir to enable blue-white selection and then transformed into S17-1
pir for
conjugation into a rifampin-resistant (Rifr) variant of the
DHEC strain. Mutations were selected by loss of the corresponding
phenotype and confirmed by Southern blotting. All Rifr
variants of DHEC strains used as recipients for conjugations were
otherwise indistinguishable from the parent.
Animal challenge.
The RITARD (reversible intestinal tie
adult rabbit diarrhea) assay was performed by the method of Albert et
al. (1). Rabbits were challenged with 1010
bacteria grown on colonization factor antigen agar and were observed for up to 7 days for diarrhea and other symptoms and for shedding of
challenge organisms. Shedding was monitored by performing daily rectal
swabbing. Animals that developed frank diarrhea were sacrificed, and
all the remaining animals were sacrificed on day eight. Following sacrifice, the rabbits were examined for gross pathological changes, and sections were taken from the midjejunum, the proximal and distal
ileum, the proximal and distal colon, the cecum (excluding the blind
segment that was surgically manipulated), the appendix, the rectum, and
the mesenteric lymph nodes. These were preserved in buffered formal
saline, sectioned, stained with hematoxylin-eosin, and examined by
light microscopy (see above). Pathological changes including
inflammation, polymorphonuclear leukocyte (PMN) infiltration, and
peritonitis were noted semiquantitatively, ranging from normal (0) or
mild (1) to severe (3).
Protein analysis.
Standard protein analysis,
SDS-polyacrylamide gel electrophoresis, immunization, Western blotting,
and immunostaining techniques were performed as outlined by Harlow and
Lane (24), unless otherwise stated. Monoclonal antibodies to
alpha-hemolysin (h2A, h11A, f11F, I1C) (25) were kindly
provided by F. Hugo, Institute of Medical Microbiology, University of
Giessen, Giessen, Germany.
For production of polyclonal antiserum to A70.1 hemolysin,
alpha-hemolysin was precipitated from broth by the method of Bhakdi et
al. (6) and subjected to SDS-polyacrylamide gel
electrophoresis. The band of interest was excised from the acrylamide
and macerated, and a 50% suspension in saline was injected
intraperitoneally into male Swiss mice on a schedule of 1, 14, 21, and
28 days; the mice were bled on day 35.
 |
RESULTS |
Cloning and characterization of alpha-hemolysin from DHEC.
A
cosmid library of A70.1 DNA was screened for production of
alpha-hemolysin, and three clones were isolated. Restriction analysis
(Fig. 1) revealed that two clones, p3E1
and p3E3, were identical and differed from a third clone, p4D3. From
p3E1, hemolytic activity was subcloned on a 28-kb SalI
fragment (giving pSE376 [Table 1]) and a 15.3-kb partial
PstI fragment (generating pSE377). pSE377 was further mapped
with probes, restriction enzymes, and transposon Tn1725
(41), which also confirmed the region containing hly (Fig. 2). Gene order was
determined with the use of a series of DNA probes directed to different
regions of the operon.

View larger version (7K):
[in this window]
[in a new window]
|
FIG. 1.
Map of the two chromosomal loci from A70.1 containing
the hlyCABD operon as predicted from the maps of cosmids
p3E1 and p4D3. The two copies of hly are designated
hlyI (in p3E1) and hlyII (in p4D3). See the text
for further details. B, BglII; Bm, BamHI; E,
EcoRI; S, SalI; ,
hly;
&atyp0220;,
cnf.
|
|

View larger version (10K):
[in this window]
[in a new window]
|
FIG. 2.
Map of fragments in pSE377, which contains
hly subcloned from cosmid p3E1 from A70.1 and is shown here
aligned with previously mapped hly loci as obtained from
reference 29 (a and b) and GenBank accession no.
M10133 and M12863 (a). B, BglII; Bm, BamHI; E,
EcoRI; P, PstI.
|
|
The hly operon of DHEC was compared to those previously
described. The restriction map and gene order were very similar to those of the chromosomally located hly of uropathogenic
E. coli (UPEC) J96 and the plasmid-borne hly from
plasmid pHly512, isolated from an animal pathogen (Fig. 2). Four
monoclonal antibodies raised against HlyA from UPEC recognized a
110-kDa supernatant protein produced by A70.1 and hly
clones. A polyclonal antiserum raised against A70.1 HlyA recognized a
similar 110-kDa band from A70.1, hly clones, and UPEC J96
(results not shown).
The remaining collection of 176 DHEC strains was examined by colony
blotting, and they all recognized hly DNA probes (see below)
and the polyclonal antiserum. Most, but not all, recognized at least
one monoclonal antibody, indicating antigenic variation in HlyA among
DHEC strains.
Cloning and analysis of CNF1 toxin production.
DHEC strains
were examined for production of CNFs and other toxins on HeLa cells. Of
177 DHEC, 54 (30.5%) (Table 2) were found to produce CNF1 toxin based on characteristic morphological alterations (Fig. 3a). There was no
evidence for production of CNF2 or verotoxins. In
strains A70.1, A98.1, and 55.3, the identity of the toxin was confirmed
by neutralization with specific antisera against CNF1, and in strain
A70.1, it was confirmed by sequence analysis (see below).

View larger version (90K):
[in this window]
[in a new window]

View larger version (80K):
[in this window]
[in a new window]

View larger version (102K):
[in this window]
[in a new window]
|
FIG. 3.
Toxin production by CDEC A70.1. (a) A70.1 bacterial cell
lysate, diluted 1:20 and inoculated onto HeLa cells. In addition to
generalized cell toxicity, two types of abnormal cells are observed:
(i) large, multinucleated cells with diffusely staining borders,
characteristic of CNF1; and (ii) densely staining, mononuclear, highly
elongated cells, referred to as spindle cells. Magnification, ×1,000.
(b) Dilution (1/80) of A70.1 lysate. Multinucleated cells are few, but
more spindle cells are observed, and they predominate in some fields.
Magnification, ×1,000. (c) Dilution (1/20) of lysate from
DH5 (pSE260), containing the cloned cnf gene from A70.1 on
a high-copy number plasmid. All cells are multinucleated. Spindle cells
are absent. Magnification, ×1,000.
|
|
CNF1 activity was encoded on cosmid clones p3E1 and p3E3 but not p4D3
and was subcloned from p3E1 as a 28-kb SalI fragment (pSE376) and a 13-kb EcoRI fragment (pSE379). Figure
4 shows the map of pSE379, illustrating
the positions of cnf and a Tn1725 insert
(described below). The restriction map of the cnf region was
similar to that in UPEC EB35 (17). Using Tn1725,
which contains an EcoRI site in the terminal repeat regions,
we were able to insert an EcoRI site that enabled us to
isolate cnf on a 4.3-kb fragment. This subclone, pSE378, was
highly active in toxin assays, with an MN50 of 1:1,280
compared to 1:40 to 1:80 for A70.1 (Fig. 3c) and strains 55.3 and
A98.1. This subclone was sequenced as a series of overlapping random
fragments. Analysis of the 4,295-bp sequence (GenBank accession no.
A42629) and the predicted translation product indicated significant DNA
and amino acid homology (99.6% amino acid identity) to cnf
from UPEC (accession no. X7670) (18). Differences occurred
in the 5' region of cnf and upstream of the gene.

View larger version (5K):
[in this window]
[in a new window]
|
FIG. 4.
Map of pSE379 containing a 13-kb gene fragment including
cnf, showing the position of the Tn1725 insertion
that added the EcoRI site. Also shown are subclones derived
from pSE379. pSE378 is a 4.3-kb EcoRI fragment cloned into
pUC18. pSE266 is a 0.95-kb Sau3AI fragment cloned into pUC18
and used as probe for cnf. B, BglII; E,
EcoRI; P, PstI; S, SalI; Sm,
SmaI.
|
|
A probe for cnf was made by cloning a 902-bp
Sau3AI fragment (corresponding to nucleotides 1061 to 1963)
from pSE378. This probe hybridized to 60 of the 177 DHEC strains,
including all the strains producing assayable toxin (Table 2), and is
90% specific and 100% sensitive for predicting CNF1 toxin production.
Identification of two chromosomal hly loci in
A70.1.
The restriction map of cosmids p3E1, p3E3, and p4D3 was
determined with the assistance of hly and cnf
probes. This demonstrated that the identical cosmids p3E1 and 3E3
carried cnf while p4D3 lacked cnf and possessed
different BglII and BamHI sites. Identically sized fragments were observed in Southern blots of chromosomal DNA,
which confirmed that A70.1 contained one cnf gene and two hly operons. These were named hlyI, which is
present on p3E1 and linked to cnf, and hlyII,
which is present on p4D3. Probing of chromosomal DNA from strains 55.3 and A98.1, as well as mutagenesis, suggested that these two isolates
also possess two hly genes and one cnf gene.
Mutagenesis of chromosomal genes in wild-type DHEC.
To
understand the role of hly and cnf in intestinal
diseases, chromosomal genes were inactivated by marker exchange
techniques. The CNF1 gene was inactivated by cloning a 1.4-kb
PstI-BglII fragment (corresponding to nucleotides
1044 to 2495 of the cnf open reading frame) into pJP5603, an
oriR6K-based suicide vector (Fig. 5). After this recombinant plasmid (pSE298) was conjugated into A70.1 Rifr, 80% (38 of 48) of the transconjugants had lost the
ability to produce CNF1 toxin. Insertion into the chromosome was
demonstrated by disruption of the 23-kb BamHI fragment. The
same technique on Rifr variants of A98.1 and 55.3 inactivated CNF1 production in 100% of transconjugants.

View larger version (9K):
[in this window]
[in a new window]
|
FIG. 5.
Derivation of fragments for recombinant suicide vectors.
A 1.4-kb BglII-PstI fragment was cloned from
cnf into pJP5603, giving pSE297, or into pJP5608, giving
pSE298. A 0.55-kb EcoRI fragment was cloned from within
hlyA into pJP5603 or pJP5608, yielding pSE346 and pSE345,
respectively. B, BglII; Bm, BamHI; E,
EcoRI; S, SalI.
|
|
To inactivate hly by this strategy, we proposed to use
suicide vectors with different antibiotic resistance markers to
inactivate the two hly genes. A 500-bp EcoRI
fragment from within hlyA from hlyI was cloned
into pJP5603, generating pSE346, which inserted into and inactivated
cloned hly genes on plasmid pSE377 (from hlyI).
When pSE346 was introduced into A70.1, it inserted into the chromosome
at hlyII in 20/20 attempts. When other fragments were cloned
from hlyI into vectors pJP5603 or pJP5608, the resultant recombinant suicide vectors always (30 of 30) inserted into
hlyII in A70.1, as seen in Southern blots of chromosomal
DNA. To inactivate hlyI, a tetracycline-resistant analog of
pSE346 was constructed by cloning the 500-bp EcoRI
hlyA fragment from hlyI into pJP5608 (a
Tcr derivative of pJP5603). In A70.1, this plasmid (pSE345)
inserted into the chromosome at hlyII and was never observed
to insert into hlyI. When pSE345 was introduced into A70.1
derivatives containing the insertion of pSE346 into hlyII
(i.e., A70.1 hlyI hlyII::pSE346), all 1,400 Tcr Kmr transconjugants screened were
hemolytic, indicating a failure to insert into and inactivate
hlyI. These data collectively indicate that hlyI
in A70.1 is resistant to mutagenesis by this strategy, possibly due to
the tertiary structure of the DNA.
This strategy was then attempted on A98.1 and 55.3 without success. The
lone exception was isolated after pSE346 was introduced into 55.3, generating a nonhemolytic variant, SE371 (Table 1). SE371 produced CNF1
and was otherwise indistinguishable from the parent, and Southern
blotting demonstrated that hlyI had been insertionally
inactivated but that the pathogenicity island containing hlyII had spontaneously excised. Given the difficulty in
constructing a nonhemolytic variant by genetic techniques, this
spontaneous mutant was used in further manipulations and was used to
construct a double mutant defective in both alpha-hemolysin and CNF1.
The CNF1-targeting pSE297 was introduced into SE371, and CNF1
production was lost in 1 (2%) of 42 strains examined. This strain,
SE372 (Table 1), lacks both Hly and CNF1 production. This and the other variants were used in animal challenge experiments.
Other toxins produced by DHEC.
A number of potentially novel
toxins appear to be produced by some DHEC strains, as observed in the
effect of freeze-thawed bacterial lysates on HeLa cells in the 72-h CNF
assay. It was demonstrated that the following phenotypes were not due
to alpha-hemolysin, since they were not mediated by the cloned
hly from A70.1 or observed in most other DHEC strains.
The first toxin caused detachment of HeLa cells in the CNF1 assay.
While CNF1 can cause limited death and detachment, 1:10- and
1:20-diluted lysates from several CNF1+ strains, including
A70.1, exhibited a pronounced cell-detaching activity that was not
observed in other CNF1+ strains. This phenomenon was not
due to CNF1, since 55.3, A98.1, and A70.1 exhibited a similar
MN50 of approximately 1:40, implying similar levels of CNF1
production, yet only A70.1 caused a complete loss of the HeLa cell
monolayer. Further, lysates from DH5
containing the cloned
cnf of A70.1(pSE378) exhibited potent multinucleating activity (MN50, 1:1,250) but did not cause detachment.
Finally, mutation of cnf in A70.1 abolished multinucleation
but not detaching activity. In addition, two DHEC isolates that did not
produce CNF1 (as determined by multinucleation of HeLa cells and DNA
probe) were cytotoxic. These results demonstrate that cell-detaching cytotoxicity exists separately from CNF1.
The second potentially novel toxin caused unusual morphological
alterations to HeLa cells. This phenotype was first identified in
lysates from A70.1, which caused (in addition to the cell enlargement, loss of border definition, and multinucleation characteristic of CNF1)
some HeLa cells to become thin and elongated, a phenomenon referred to
as spindle cells (Fig. 3). Dilution of A70.1 lysates led to reduced
multinucleating and enlarging activity but had less effect on
spindle-forming activity, and at a 1:80 dilution, spindle cells
dominated some fields (Fig. 3b). This activity was not observed in the
lysates from the cnf clone (Fig. 3c). This demonstrates that
CNF1 activity is distinct from spindle-forming activity. However,
insertional inactivation of cnf in A70.1 caused a marked
reduction in the spindle-forming activity of lysates. Although it is
possible that CNF1 potentiates the spindle-forming factor, it appears
unusual that two toxins with completely opposite toxic effects could
act synergistically. CNF1 leads to large, rounded cells with diffusely
staining cytoplasm, while spindle cells are extremely elongated and
mononuclear, with a normally staining cytoplasm.
Animal challenge experiments.
Animal models were used to
evaluate DHEC enteropathogenicity. Oral inoculation of
streptomycin-treated specific-pathogen-free mice and rabbit ileal loops
were attempted. While some colonization and pathological changes were
observed, virulence was difficult to reproduce and was often mild or
moderate, and so these models were abandoned (results not shown).
In the RITARD model, DHEC strains exhibited virulence with a set of
clear, unique pathologic findings. Rabbits infected with DHEC exhibited
depression, cramping, and diarrhea which ranged from mild to frank
(Table 3). All rabbits that developed
frank diarrhea produced mucoid diarrhea with anal staining. Some
rabbits died. At sacrifice, there was evidence of fluid accumulation in the small and large intestines, sometimes with mucus and blood. Infected animals showed a number of marked histological changes in both
the small and large intestines (Fig. 6).
These included multifocal areas of mucosal erosion and necrosis,
hyperemia, and colonic goblet cell hyperplasia. The level of
hyperplasia was remarkable, and the mucosa in rabbits infected with
strain A70.1 was observed to be 2 to 3 times the normal thickness.
Other inflammatory changes included activation of the Peyer's patches,
PMN infiltration into the lamina propria and lumen, edema, and
lymphocytic hyperplasia. However, the pathologic findings varied with
each rabbit and infecting organism. In contrast, rabbits infected with
the negative control E. coli C600 did not develop diarrhea
and their intestines were entirely normal. It is clear that DHEC
strains are more virulent in RITARD than is C600 and, overall, that
DHEC strains are significantly (
2, P < 0.05) associated with diarrhea. To compare histopathological changes,
outcomes were scored semiquantitatively (Table
4). By using this approach, it was
evident that there was considerable variation between DHEC strains but
that, overall, DHEC strains were significantly (t test,
P < 0.05) associated with inflammation and that more
inflammatory changes were observed in the large intestine.

View larger version (143K):
[in this window]
[in a new window]
|
FIG. 6.
Histopathological changes to rabbit intestines after
challenge with A70.1. (a) Multifocal areas of mucosal erosion with
submucosal accumulation of neutrophils and lymphocytes, capillary
congestion, and lacteal dilatation. Rabbit ileum stained with
hemotoxylin and eosin. Magnification, ×400. (b) Diffuse presence of
active germinal centers in Peyer's patches along the length of the
ileum with a marked increase in the number of intraepithelial
lymphocytes (arrow) and tingible-body macrophages. Rabbit ileum,
stained with hemotoxylin and eosin. Magnification, ×400.
|
|
To examine the role of different virulence factors in DHEC-mediated
enteric disease, we compared rabbits infected with either wild-type
DHEC strains, isogenic mutants, C600 containing cloned DHEC virulence
genes, or C600. All rabbits infected with a C600 strain containing
hlyI cloned on a high-copy-number vector developed frank
diarrhea and showed marked inflammatory reactions in both small and
large intestine. This clone was significantly more (
2,
P < 0.05) likely to cause diarrhea than was the
plasmid-free variant, suggesting that cloned hly is able to
confer virulence upon nonpathogenic E. coli strains. Rabbits
infected with the CNF1+ clone developed diarrhea yet were
not statistically more likely to develop diarrhea than were controls
(
2, P < 0.05). They also exhibited
intestinal inflammation, although less than that observed in rabbits
infected with the hemolytic clone.
Paradoxically, the loss of either hly or cnf from
DHEC 55.3 did not lead to a measurable reduction in disease, as
measured by diarrheagenicity or histopathological changes, and these
strains remained more virulent than C600. However, loss of both CNF1
and hemolysin production was associated with low intestinal
inflammation (Tables 3 and 4). These results suggest that other
virulence factors are present in DHEC strains and complicate our
understanding of the role of hly in DHEC-associated
diarrhea.
 |
DISCUSSION |
DHEC strains were initially described as a class of E. coli that were significantly more common in children with diarrhea than in controls (22). To examine the diarrheagenic ability of DHEC in vivo, we used the RITARD model, in which the effect of each
strain on the entire gut of a rabbit is examined for up to a week. In
this model, DHEC strains caused frank mucoid diarrhea and a set of
clear, unique, and marked intestinal pathologic findings in both the
small and large intestines, including necrosis, hyperplasia, and
multiple indicators of inflammation. In contrast, avirulent E. coli C600 caused no pathologic effects or diarrhea in rabbits.
The mechanism by which DHEC strains caused enteric disease was unknown
as they lacked traditional diarrheal virulence factors (22).
All DHEC strains produced alpha-hemolysin, and we have demonstrated
that DHEC hemolysin could not be significantly distinguished from UPEC
hemolysin on the basis of the restriction map, DNA hybridization, protein size, or antibody reactivity. Since the role of hemolysin in
enteric disease is unresolved, we sought other toxins among DHEC
strains that may explain their apparent diarrheagenicity. Approximately
one-third of isolates produced CNF1 toxin, as demonstrated by the toxin
assay and DNA hybridization. The analysis of cnf in A70.1
indicates that it is very similar to cnf from UPEC. There is
evidence in a few DHEC isolates for two novel toxins which are
phenotypically and genotypically distinct from alpha-hemolysin and
CNF1. The first toxin is a HeLa cell cytotoxin found in A70.1 and some
other DHEC strains. The second toxin observed in A70.1 possessed
spindle-forming activity, since bacterial lysates caused a subset of
HeLa cells to become densely staining, thin and elongated. While this
was not mediated by cnf, mutation of cnf in the
wild type markedly reduced spindle-forming activity. It is possible that CNF1 is necessary to potentiate toxin activity or, more likely, that mutation has had polar effects on downstream genes. It is not
known what is encoded downstream of cnf.
Since the majority of DHEC strains do not appear to produce toxins
other than hemolysin and CNF1, we examined the role of these factors in
DHEC-induced disease with wild-type strains, clones, and mutant
variants. The evidence from cloned hly supports its role as
a virulence factor. When hly was cloned on a
high-copy-number vector, it conferred on avirulent C600 the ability to
cause diarrhea in rabbits and other pathologic changes. Notably,
hemolysin appeared to be associated with inflammation, especially in
the colon. By using statistical tests, the presence of both plasmid
pSE377 (hly) and the hly gene was significantly
associated with diarrhea. In contrast, the cloned cnf gene
could not be demonstrated statistically to cause diarrhea, and so its
role, if any, in this model of disease appears to be minor.
Complicating this analysis, however, is the data obtained from isogenic
mutants of DHEC 55.3. Mutagenesis of cnf, hly, or both did not significantly affect the onset, duration, or severity of
diarrhea, although loss of both was associated with a decrease in
intestinal inflammation. This indicates that factors in strain 55.3 other than cnf or hly may also mediate diarrhea
in the RITARD model, suggesting multiple virulence mechanisms.
In summary, the data suggests that DHEC strains are virulent and that
alpha-hemolysin, the factor shared among all DHEC strains, is a
virulence factor. This supports our initial epidemiologic observation
linking hemolysin to diarrhea and agrees with other studies that found
statistically significant associations and/or linkage to a particular
outbreak (8-13, 20-22, 33, 36, 43, 44). Further, it
supports the findings of Wray et al. (45), who demonstrated
that Hly+ CNF1+ strains from pigs were virulent
in piglets and caused pathologic changes generally similar to those
observed by us, including diarrhea, death, and effects on both small
and large intestines such as edema, inflammation, and necrosis. Rather
than following classic secretory diarrhea, the disease was closer to
that due to proinflammatory and invasive pathogens. The strains studied
by Wray et al. (45) appeared to be more virulent in the
piglet model, possibly reflecting their challenge of piglets with pig
pathogens compared to our challenging of rabbits with human pathogens.
We propose several modes by which alpha-hemolysin could act as a
diarrheal toxin. The first involves pore formation in the enterocytes,
allowing the free flow of ions into the lumen. This may be enhanced by
a Ca2+ flux into the cell, stimulating the arachidonic acid
pathway and upregulation of secretion, or by generalized cytotoxicity, perturbing both secretion and absorbtion. Other pore-forming hemolysins shown to cause diarrhea include Vibrio cholerae El Tor
hemolysin (39), Vibrio parahaemolyticus TDH
(28), Serpulina hyodysenteriae hemolysin
(40), and delta-hemolysin of Staphylococcus
aureus (27). Because DHEC diarrhea appears to be
associated with marked inflammation, this suggests that the
inflammatory effects of hemolysin seen in extraintestinal infections
and in vitro (7, 9, 16, 42, 43) are present in intestinal
infection and may be important in diarrhea.
If we are to consider alpha-hemolysin to be an enteric virulence factor
and DHEC strains to be diarrheal pathogens, it is possible that UPEC
strains are also enterovirulent. Certainly, the virulence factors
observed in DHEC strains did not distinguish them from uropathogens,
and it is unclear if DHEC strains are uropathogenic organisms
functioning as enteric pathogens or are specialized enteric pathogens.
The common dogma that divides intestinal from extraintestinal E. coli pathogens may be an oversimplification that needs to be
reexamined. However, it is possible that specific factors such as a
specialized HlyA type are present in DHEC strains and are functionally
different from those in UPEC strains.
It has been demonstrated that hly from different isolates
may be more than 95% homologous but can differ markedly in the
regulation of expression, HlyA stability, and virulence (4,
23). This was most elegantly shown in an animal model of UPEC
pathogenesis (23). Deletion of a chromosomally encoded
hly from a human UPEC led to a significant reduction in
toxicity for mice, and reintroduction of hly cloned from the
chromosomes of various UPEC strains on a recombinant plasmid restored
toxicity. However, hly isolated from a plasmid of an animal
enteropathogen led to a very marginal increase in toxicity despite
being very highly related to hly of UPEC strains. Therefore,
the marked similarities of DHEC hly to both UPEC
hly and animal enteropathogen hly may nonetheless mask real and significant differences that are relevant to pathogenesis in this model. Indeed, we have observed with monoclonal antibodies that
DHEC produce different HlyA subtypes that cluster with other virulence
factors (unpublished data). This linkage suggests that there are DHEC
subtypes that may cause different types of disease, with only certain
categories responsible for diarrhea, and may explain why the
epidemiologic link to diarrhea is often not as strong as that for
"classic" enteropathogens.
Finally, we must address the findings of earlier workers, who were
unable to demonstrate a role for hemolysin in enteric disease. As
outlined above, the type of hly used may be a crucial
factor. Thus, while DHEC hly may be a virulence factor, this
is unlikely to apply to hly from all E. coli
strains. Second, most studies have attempted to demonstrate
diarrheagenicity in short-lived models appropriate for classic
secretory toxins (e.g., cholera toxin) such as the rabbit ileal loop
and have used toxin preparations despite HlyA being very labile. We
would not expect that the type of disease observed with DHEC would
yield a positive result in these studies, and we were unable to show
virulence in the rabbit ileal loop. Marked disease was observed only
several days after whole bacteria were inoculated into the RITARD
model, and most pathologic findings were observed in the large
intestine.
In conclusion, we believe that DHEC strains are potential
enteropathogens and that the variant of alpha-hemolysin encoded on the
chromosome is an important but by no means the only virulence factor in
the RITARD model of infection. We believe that these preliminary
results call for further experiments, including experiments with larger
groups of animals and those with more precisely defined measures of
pathogenesis. Finally, we believe that this result may eventually cause
us to redefine the distinction between uropathogens and enteropathogens
and how a factor that promotes virulence in one site may function in
another. Certainly, the way in which UPEC interacts with the intestine
may determine its ability to subsequently cause urinary tract
infection.
 |
ACKNOWLEDGMENTS |
We thank M. M. Islam, ICDDR,B, for the main body of RITARD
model studies; A. Joseph, M. Beach, and P. Kumar for assistance with
RITARD at the CVD; and J. Nataro and J. Kaper for advice and support.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Center for
Vaccine Development, University of Maryland School of Medicine, 685 W
Baltimore St., Baltimore, MD 21201. Phone: (410) 706 2493. Fax: (410)
706 6205. E-mail: selliott{at}umaryland.edu.
Editor: P. E. Orndorff
 |
REFERENCES |
| 1.
|
Albert, M. J.,
K. Alam,
M. Ansaruzzaman,
M. M. Islam,
A. S. M. H. Rahman,
K. Haider,
N. A. Bhuiyan,
N. Ryan,
J. Montanaro, and M. M. Mathan.
1992.
Pathogenesis of Providencia alcalifaciens-induced diarrhea.
Infect. Immun.
60:5017-5024[Abstract/Free Full Text].
|
| 2.
|
Ausubel, F. M.,
R. Brent,
R. E. Kingston, et al.
1987.
In
Current protocols in molecular biology, p. 2.4.1-2.4.5.
Green Publishing Associates and Wiley-Interscience, New York, N.Y.
|
| 3.
|
Bankier, A. T.,
K. M. Weston, and B. G. Barrell.
1987.
Random cloning and sequencing by the M13/dideoxy chain termination method.
Methods Enzymol.
155:51-93[Medline].
|
| 4.
|
Benz, R.,
A. Döbereiner,
A. Ludwig, and W. Goebel.
1992.
Haemolysin of Escherichia coli: comparison of pore-forming properties between chromosome and plasmid-encoded haemolysins.
FEMS Microbiol. Lett.
105:55-62.
|
| 5.
|
Beutin, L.
1991.
The different haemolysins of Escherichia coli.
Med. Microbiol. Immunol.
180:167-182[Medline].
|
| 6.
|
Bhakdi, S.,
N. Mackman,
J. Nicaud, and I. Holland.
1986.
Escherichia coli hemolysin may damage target cell membranes by generating transmembrane pores.
Infect. Immun.
52:63-69[Abstract/Free Full Text].
|
| 7.
|
Bhakdi, S., and E. Martin.
1991.
Superoxide generation by human neutrophils induced by low doses of Escherichia coli hemolysin.
Infect. Immun.
59:2955-2962[Abstract/Free Full Text].
|
| 8.
|
Blanco, J.,
E. A. González,
P. Espinosa,
M. Blanco,
J. I. Garabal, and M. P. Alonso.
1992.
Enterotoxigenic and necrotizing Escherichia coli in human diarrhoea in Spain.
Eur. J. Epidemiol.
8:548-552[Medline].
|
| 9.
|
Braun, V., and T. Focareta.
1991.
Pore-forming bacterial protein hemolysins (cytolysins).
Crit. Rev. Microbiol.
18:115-158[Medline].
|
| 10.
|
Caprioli, A.,
V. Falbo,
L. G. Roda,
F. M. Ruggeri, and C. Zona.
1983.
Partial purification and characterization of an Escherichia coli toxic factor that induces morphological cell alterations.
Infect. Immun.
39:1300-1306[Abstract/Free Full Text].
|
| 11.
|
Colonna, B.,
L. Ranucci,
P. A. Fradiani,
M. Casalino,
A. Calconi, and M. Nicoletti.
1992.
Organisation of aerobactin, hemolysin, and antibacterial resistance genes in lactose-negative Escherichia coli strains of serotype O4 isolated from children with diarrhoea.
Infect. Immun.
60:5224-5231[Abstract/Free Full Text].
|
| 12.
|
Czirok, E.
1985.
Virulence factors of Escherichia coli. II. Antigens O4, O6 and O18, haemolysin production and mannose resistant haemagglutinating capacity are closely associated.
Acta Microbiol. Hung.
32:183-192[Medline].
|
| 13.
|
DeRycke, J.,
J. F. Guillot, and R. Boivin.
1987.
Cytotoxins in non-enterotoxigenic strains of Escherichia coli isolated from feces of diarrheic calves.
Vet. Microbiol.
15:137-150[Medline].
|
| 14.
|
DeRycke, J.,
E. A. González,
J. Blanco,
E. Oswald,
M. Blanco, and R. Boivin.
1990.
Evidence for two types of cytotoxic necrotizing factor in human and animal clinical isolates of Escherichia coli.
J. Clin. Microbiol.
28:694-699[Abstract/Free Full Text].
|
| 15.
|
Elliott, S. J., and J. P. Nataro.
1995.
Enteroaggregative and diffusely adherent Escherichia coli.
Rev. Med. Microbiol.
6:196-206.
|
| 16.
|
Ermert, L.,
S. Rousseau,
H. Schütte,
R. G. Birkemeyer,
F. Grimminger,
S. Bhakdi,
H. R. Duncker, and W. Seeger.
1992.
Induction of severe vascular leakage by low doses of Escherichia coli hemolysin in perfused rabbit lungs.
Lab. Invest.
66:362-369[Medline].
|
| 17.
|
Falbo, V.,
M. Famigletti, and A. Caprioli.
1992.
Gene block encoding production of cytotoxic necrotizing factor 1 and haemolysin in Escherichia coli isolates from extraintestinal infections.
Infect. Immun.
60:2182-2187[Abstract/Free Full Text].
|
| 18.
|
Falbo, V.,
T. Pace,
L. Picci,
E. Pizzi, and A. Caprioli.
1993.
Isolation and nucleotide sequence of the gene encoding cytotoxic necrotizing factor 1 of Escherichia coli.
Infect. Immun.
61:4909-4914[Abstract/Free Full Text].
|
| 19.
|
Fiorentini, C.,
G. Donelli,
P. Mataresse,
A. Fabbri,
S. Paradisi, and P. Boquet.
1995.
Escherichia coli cytotoxic necrotizing factor 1: evidence for induction of actin assembly by constitutive activation of the p21 Rho GTPase.
Infect. Immun.
63:3936-3944[Abstract].
|
| 20.
|
Gaillard, J. I.,
G. Cheron,
J. F. Mougenot,
J. P. Deslys,
C. Nezelhof,
M. Veron, and J. Smitz.
1989.
Pyelonephritic Escherichia coli strains as intestinal pathogens in two newborn infants.
Lancet
i:327-328.
|
| 21.
|
Giugliano, L. G.,
C. J. B. Meyer,
L. C. Arantes,
S. T. G. Ribeiro, and R. Giugliano.
1993.
Mannose-resistant haemagglutination and haemolysin production of strains of Escherichia coli isolated from children with diarrhoea: effect of breastfeeding.
J. Trop. Pediatr.
39:183-187[Abstract/Free Full Text].
|
| 22.
|
Gunzburg, S. T.,
B. J. Chang,
S. J. Elliott,
V. Burke, and M. Gracey.
1993.
Diffuse and enteroaggregative patterns of adherence of enteric Escherichia coli isolated from Aboriginal children from the Kimberley region of Western Australia.
J. Infect. Dis.
167:755-758[Medline].
|
| 23.
|
Hacker, J.,
C. Hughes,
H. Hof, and W. Goebel.
1983.
Cloned hemolysin genes from Escherichia coli that cause urinary tract infection determine different levels of toxicity in mice.
Infect. Immun.
42:57-63[Abstract/Free Full Text].
|
| 23a.
| Hampson, D. Personal communication.
|
| 24.
|
Harlow, E., and D. Lane.
1988.
In
Antibodies: a laboratory manual.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 25.
|
Hugo, F.,
M. Arvand,
J. Reichwein,
N. Mackman,
I. B. Holland, and S. Bhakdi.
1987.
Identification with monoclonal antibodies of hemolysin produced by clinical isolates of Escherichia coli.
J. Clin. Microbiol.
25:26-30[Abstract/Free Full Text].
|
| 26.
|
Johnson, J. R.
1991.
Virulence factors in Escherichia coli urinary tract infection.
Clin. Microbiol. Rev.
4:80-128[Abstract/Free Full Text].
|
| 27.
|
Kapral, F. A.
1985.
Staphylococcus aureus delta toxin as an enterotoxin.
Ciba Found. Symp.
112:215-229[Medline].
|
| 28.
|
Nishibuchi, M.,
A. Fasano,
R. G. Russell, and J. B. Kaper.
1992.
Enterotoxigenicity of Vibrio parahaemolyticus with and without genes encoding thermostable direct hemolysin.
Infect. Immun.
60:3539-3545[Abstract/Free Full Text].
|
| 29.
|
Noegel, A.,
U. Rdest, and W. Goebel.
1981.
Determination of the functions of hemolytic plasmid pHly152 of Escherichia coli.
J. Bacteriol.
145:233-247[Abstract/Free Full Text].
|
| 30.
|
Oswald, E.,
J. DeRycke,
P. Lintermans,
K. VanMuylem,
J. Mainil,
G. Daube, and P. Pohl.
1991.
Virulence factors associated with cytotoxic necrotizing factor type two in bovine diarrheic and septicemic strains of Escherichia coli.
J. Clin. Microbiol.
29:2522-2527[Abstract/Free Full Text].
|
| 31.
|
Oswald, E.,
M. Sugai,
A. Labigne,
H. C. Wu,
C. Fiorentini,
P. Boquet, and A. D. O'Brien.
1994.
Cytotoxic necrotizing factor type 2 produced by virulent Escherichia coli modifies the small GTP-binding proteins Rho involved in assembly of actin stress fibers.
Proc. Natl. Acad. Sci. USA
91:3814-3818[Abstract/Free Full Text].
|
| 32.
|
Penfold, R. J., and J. M. Pemberton.
1992.
An improved suicide vector for construction of chromosomal insertion mutations in bacteria.
Gene
118:145-146[Medline].
|
| 33.
|
Prada, J.,
G. Baljer,
J. DeRycke,
H. Steinrück,
S. Zimmerman,
R. Stephan, and L. Beutin.
1991.
Characteristics of -haemolytic strains of Escherichia coli isolated from dogs with gastroenteritis.
Vet. Microbiol.
29:59-73[Medline].
|
| 34.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
In
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 35.
|
Schmidt, H.,
L. Beutin, and H. Karch.
1995.
Molecular analysis of the plasmid-encoded hemolysin of Escherichia coli O157:H7 strain EDL 933.
Infect. Immun.
63:1055-1061[Abstract].
|
| 36.
|
Shimizu, M., and T. Terashima.
1982.
Appearance of enterotoxigenic Escherichia coli strains in piglets with diarrhoea in connection with feed changes.
Microbiol. Immunol.
26:467-477[Medline].
|
| 37.
|
Smith, H. W., and M. A. Linggood.
1971.
Observations on the pathogenic properties of the K88, Hly and Ent plasmids of Escherichia coli with particular reference to porcine diarrhoea.
J. Med. Microbiol.
4:467-485[Medline].
|
| 38.
|
Spratt, B. G.,
P. J. Hedge,
S. te Heesen,
A. Edelman, and J. K. Broome-Smith.
1986.
Kanamycin-resistant vectors that are analogues of plasmids pUC8, pUC9, pEMBL8, pEMBL9.
Gene
41:337-342[Medline].
|
| 39.
|
Tacket, C. O.,
G. Losonsky,
J. P. Nataro,
S. J. Cryz,
R. Edelman,
A. Fasano,
J. Michalski,
K. B. Kaper, and M. M. Levine.
1993.
Safety and Immunogenicity of live cholera vaccine candidate CVD 110, a ctxA zot ace derivative of El Tor Ogawa Vibrio cholerae.
J. Infect. Dis.
168:1536-1540[Medline].
|
| 40.
|
Ter Huune, A. A. H. M.,
S. Muir,
M. Van Houten,
M. B. H. Koopman,
J. G. Kusters,
B. A. M. van der Zeijst, and W. Gaastra.
1993.
The role of hemolysin in the pathogenesis of Serpulina hyodysenteriae.
Zentralbl. Bakteriol.
278:316-325[Medline].
|
| 41.
|
Ubben, D., and R. Schmitt.
1986.
Tn1725 derivatives for transposon mutagenesis, restriction mapping and nucleotide sequence analysis.
Gene
41:145-152[Medline].
|
| 42.
|
Welch, R. A.
1991.
Pore-forming cytolysins of Gram-negative bacteria.
Mol. Microbiol.
5:521-528[Medline].
|
| 43.
|
Welch, R. A.,
C. Forestier,
A. Lobo,
S. Pellett,
W. Thomas, Jr., and G. Rowe.
1992.
The synthesis and function of the Escherichia coli hemolysin and related RTX exotoxins.
FEMS Microbiol. Immunol.
105:29-36.
|
| 44.
|
Wray, C.,
D. W. T. Piercy,
P. J. Carroll,
C. T. Johnson, and R. J. Higgins.
1992.
Bovine haemorrhagic colitis associated with CNF+ and F6+(987P) E. coli.
Vet. Rec.
131:220[Medline].
|
| 45.
|
Wray, C.,
D. W. T. Piercy,
P. J. Carrol, and W. A. Cooley.
1993.
Experimental infection of neonatal pigs with CNF toxin producing strains of Escherichia coli.
Res. Vet. Sci.
54:290-298[Medline].
|
Infect Immun, May 1998, p. 2040-2051, Vol. 66, No. 5
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Morgan, E., Bowen, A. J., Carnell, S. C., Wallis, T. S., Stevens, M. P.
(2007). SiiE Is Secreted by the Salmonella enterica Serovar Typhimurium Pathogenicity Island 4-Encoded Secretion System and Contributes to Intestinal Colonization in Cattle. Infect. Immun.
75: 1524-1533
[Abstract]
[Full Text]
-
Wu, X.-Y., Chapman, T., Trott, D. J., Bettelheim, K., Do, T. N., Driesen, S., Walker, M. J., Chin, J.
(2007). Comparative Analysis of Virulence Genes, Genetic Diversity, and Phylogeny of Commensal and Enterotoxigenic Escherichia coli Isolates from Weaned Pigs. Appl. Environ. Microbiol.
73: 83-91
[Abstract]
[Full Text]
-
Mysorekar, I. U., Hultgren, S. J.
(2006). Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract. Proc. Natl. Acad. Sci. USA
103: 14170-14175
[Abstract]
[Full Text]
-
Sobieszczanska, B. M., Osek, J., Gryko, R., Dobrowolska, M.
(2006). Association between cell-bound haemolysin and cell-detaching activity of Escherichia coli isolated from children.. J Med Microbiol
55: 325-330
[Abstract]
[Full Text]
-
Hopkins, A. M., Walsh, S. V., Verkade, P., Boquet, P., Nusrat, A.
(2003). Constitutive activation of Rho proteins by CNF-1 influences tight junction structure and epithelial barrier function. J. Cell Sci.
116: 725-742
[Abstract]
[Full Text]
-
PACIOREK, J.
(2002). Virulence properties of Escherichia coli faecal strains isolated in Poland from healthy children and strains belonging to serogroups O18, O26, O44, O86, O126 and O127 isolated from children with diarrhoea. J Med Microbiol
51: 548-571
[Abstract]
[Full Text]
-
Okeke, I. N., Steinruck, H., Kanack, K. J., Elliott, S. J., Sundstrom, L., Kaper, J. B., Lamikanra, A.
(2002). Antibiotic-Resistant Cell-Detaching Escherichia coli Strains from Nigerian Children. J. Clin. Microbiol.
40: 301-305
[Abstract]
[Full Text]
-
Rippere-Lampe, K. E., O'Brien, A. D., Conran, R., Lockman, H. A.
(2001). Mutation of the Gene Encoding Cytotoxic Necrotizing Factor Type 1 (cnf1) Attenuates the Virulence of Uropathogenic Escherichia coli. Infect. Immun.
69: 3954-3964
[Abstract]
[Full Text]
-
Guignot, J., Breard, J., Bernet-Camard, M.-F., Peiffer, I., Nowicki, B. J., Servin, A. L., Blanc-Potard, A.-B.
(2000). Pyelonephritogenic Diffusely Adhering Escherichia coli EC7372 Harboring Dr-II Adhesin Carries Classical Uropathogenic Virulence Genes and Promotes Cell Lysis and Apoptosis in Polarized Epithelial Caco-2/TC7 Cells. Infect. Immun.
68: 7018-7027
[Abstract]
[Full Text]
-
Fournout, S., Dozois, C. M., Odin, M., Desautels, C., Peres, S., Herault, F., Daigle, F., Segafredo, C., Laffitte, J., Oswald, E., Fairbrother, J. M., Oswald, I. P.
(2000). Lack of a Role of Cytotoxic Necrotizing Factor 1 Toxin from Escherichia coli in Bacterial Pathogenicity and Host Cytokine Response in Infected Germfree Piglets. Infect. Immun.
68: 839-847
[Abstract]
[Full Text]
-
Fernandez-Prada, C., Tall, B. D., Elliott, S. E., Hoover, D. L., Nataro, J. P., Venkatesan, M. M.
(1998). Hemolysin-Positive Enteroaggregative and Cell-Detaching Escherichia coli Strains Cause Oncosis of Human Monocyte-Derived Macrophages and Apoptosis of Murine J774 Cells. Infect. Immun.
66: 3918-3924
[Abstract]
[Full Text]